FRIDAY, Jan. 7, 2022 (HealthDay News) — A review of cases from 465 U.S. hospitals underscores the protection provided by COVID-19 vaccines. The new review — by researchers at the U.S. National Institutes of Health — found that vaccinated adults who got breakthrough infections rarely got severely ill. Respiratory failure,Continue Reading

FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading